The Global Veterinary Molecular Diagnostics Market is projected to be valued at USD 194.47 million in 2023 and is expected to surpass USD 377.22 million by 2033. This growth is driven by a compound annual growth rate (CAGR) of 6.84% during the forecast period from 2023 to 2033.
Key Market Drivers
The increasing demand for rapid and accurate diagnostic testing for various veterinary diseases is a key factor driving the growth of the veterinary molecular diagnostics market. Molecular diagnostics offer enhanced sensitivity and specificity compared to traditional diagnostic methods, enabling the early detection of infectious diseases in animals. As pet ownership continues to rise globally and the focus on animal health strengthens, veterinary diagnostics are becoming more critical to ensure animal welfare and public health.
Furthermore, advancements in molecular testing technologies, along with rising investments in veterinary healthcare infrastructure, are expected to significantly contribute to market growth.
Key Takeaways
- Market Value in 2023: USD 194.47 million
- Projected Market Value by 2033: USD 377.22 million
- CAGR: 6.84% from 2023 to 2033
- Growth Drivers: Increasing demand for rapid diagnostics, advancements in molecular technologies, and growing investments in veterinary healthcare.
Regional Insights
- North America: Holds the largest market share due to high pet ownership rates, strong healthcare infrastructure, and advanced veterinary diagnostics.
- Europe: A significant market driven by increasing awareness of animal diseases and a growing focus on veterinary healthcare.
- Asia-Pacific: Expected to witness strong growth due to rising demand for advanced veterinary care, increasing pet adoption, and improving healthcare systems in countries like China and India.
- Latin America & Middle East/Africa: Emerging markets where the demand for veterinary diagnostics is growing due to an expanding veterinary industry and rising animal healthcare needs.
Market Overview
- 2023 Estimated Value: USD 194.47 million
- 2033 Projected Value: USD 377.22 million
- CAGR (2023-2033): 6.84%
Key Insights
Veterinary molecular diagnostics involves advanced techniques used to detect diseases in animals at the molecular level, enhancing the ability to diagnose conditions accurately and efficiently. The increasing demand for rapid and precise diagnostic tools in veterinary medicine is driving market growth.
Growth Drivers
Several factors are contributing to the expansion of the veterinary molecular diagnostics market:
- Rising Incidence of Animal Diseases: The growing prevalence of infectious and chronic diseases among pets and livestock is increasing the need for effective diagnostic solutions.
- Technological Advancements: Innovations in molecular diagnostic technologies are improving the speed and accuracy of disease detection, making them more accessible to veterinary practices.
- Increased Pet Ownership: The rising trend of pet ownership globally is leading to greater investment in veterinary health, including diagnostic services.
Get Complete Full Report
Key Companies Profiled
- bioMérieux SA
- IDEXX Laboratories, Inc.
- Neogen Europe, Ltd.
- Veterinary Molecular Diagnostics, Inc.
- Thermo Fisher Scientific, Inc.
- ID-Vet, Qiagen N.V.
Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis
By Product Type:
- PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits
- INAAT Kits
- Microarray Kits
- DNA Sequencing Kits
By Species Type:
- Livestock Animals
- Equine
- Porcine
- Poultry
- Cattle
- Aquatic
- Ovine
- Companion Animals
- Canine
- Feline
- Avian
By Disease Type:
- Anaplasma spp.
- Ehrlichia spp.
- New Castle Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
By End User:
- Veterinary Hospitals
- Clinical Laboratories
- Veterinary Research Institutes
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
